hera

Guiding Precision Therapies for Seizures

Alterations in the SCN2A gene influence the age of seizure onset and the severity of neurological impairments in affected children, aiding in the identification




hera

Gene Therapy Restores Vision for Patients Born Blind

Patients born with genetic medlinkblindness/medlink experienced significant visual improvements after a single treatment with gene therapy developed




hera

Monoclonal Antibodies: Revolutionizing Drug Therapies

Monoclonal antibodies (mAbs) are special proteins used to help prevent, detect, and treat a wide range of diseases, both infectious and non-infectious.




hera

Fat-Derived Cellular Therapy: A New Hope for Diabetes Treatment

Fat-Derived cellular therapy offers a promising new approach for diabetes, using cells from body fat to improve insulin function and potentially reverse the disease.




hera

Truth About Using Shockwave Therapy for Erectile Dysfunction

Erectile dysfunction (ED) is a condition that affects millions of men throughout the world. It can occur at any age and have an impact on the quality of someone's life.




hera

Remodelling Signal Pathways in Prostate Cancer - A New Therapeutic Target!

medlinkCancer/medlink-causing mutations in prostate cancer hyperactivate PI3K signaling, leading to cancer cell growth. PLEKHS1, a largely unknown




hera

Combination Therapy Holds Promise for Advanced Prostate Cancer Treatment

Decitabine, a medlinkprostate cancer/medlink drug, that inhibits DNA methylation, effectively cuts tumor growth in prostate cancer with neuroendocrine features or loss of the gene RB1.




hera

How Oncolytic Virotherapy Helped Beat Breast Cancer

Discover how Beata Halassy, a virologist, used oncolytic virotherapy to treat her breast cancer successfully.




hera

Actress Samantha Underwent Hyperbaric Oxygen Therapy for Myositis

bHighlights:/bul class="group-list punch-points" liActress Samantha Ruth Prabhu open about her health struggles on social media in late 2022/li liShe




hera

Princess of Wales Begins Chemotherapy in Cancer Battle

Catherine, the Princess of Wales, has disclosed her cancer diagnosis and is currently undergoing medlinkchemotherapy/medlink (!--ref1--) treatment.




hera

Combination Therapy Reduces Blood Pressure With Ibrutinib Treatment

Combining two or more blood pressure medications can markedly medlinklower blood pressure/medlink in patients on ibrutinib. (!--ref1--) Targeted




hera

Study Reveals Why HIV Remains in Human Tissue Even After Antiretroviral Therapy

A new study conducted by researchers reveals a possible answer to the mystery of why infected people can't get rid of HIV altogether. In HIV patients,




hera

Promising Tuberculosis Therapy for HIV-positive Patients

A promising new therapy for medlinktuberculosis/medlink (TB) has been shown to be compatible with combined antiretroviral therapy (cART), stated research




hera

Long-Term Relief: Low-dose Antiviral Therapy Eases Eye Disease and Shingles Pain

Long-term, low-dose antiviral treatment lowers the risk of vision-damaging inflammation, infection, and pain from shingles affecting the eye, according




hera

Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety Goal

Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission P




hera

Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements

Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements




hera

Anthera Issues First Quarter 2010 Financial Report

Anthera Issues First Quarter 2010 Financial Report




hera

Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology

Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology




hera

Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference




hera

New Campaign: Estrogen Therapy I.Q. (ETIQ) Kicks Off to Improve Access to Credible Facts About Menopause and Advances in Estrogen Therapy

New Campaign: Estrogen Therapy I.Q. (ETIQ) Kicks Off to Improve Access to Credible Facts About Menopause and Advances in




hera

Halozyme Therapeutics Reports First Quarter 2010 Financial Results

Halozyme Therapeutics Reports First Quarter 2010 Financial Results




hera

Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study

Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study




hera

Artificial Intelligence Revolutionizes the Future of Cancer Therapy

According to health experts, medlinkartificial intelligence/medlink (AI) is advancing cancer treatment, enhancing traditional methods like medlinkchemotherapy/medlink,




hera

AI Breakthrough: Accelerating Effective Antibiotic Therapy for Sepsis

medlinkSepsis/medlink poses a life-threatening infection complication, leading to 1.7 million hospitalizations and 350,000 deaths annually in the U.




hera

Advancing Heart Treatment in India With AI-Driven Therapies

Experts emphasize that Artificial Intelligence (AI) has the potential to transform heart disease treatment in India by enabling early detection and personalized




hera

Gene Therapy Converts Omega-6 to Omega-3 Fatty Acids to Combat Arthritis

medlinkChildhood obesity/medlink, affecting nearly 20% of children and teens, has severe implications for their health, increasing the risk of medlinkarthritis/medlink,




hera

Progress of Plant-made Vaccines and Therapeutics

Advances in technology and manufacturing could boost the uptake of therapeutics derived from plants. Therapeutic proteins such as antibodies, hormones,




hera

Aromatherapy can Reduce Post-surgical Opioid Use by Half: Study

Post-surgical opioid use in hip replacement patients can be reduced by half with aromatherapy, reveals a new study. The new preliminary was study




hera

AstraZeneca Collaborates With Wallenberg for Developing Secretome Therapeutics

London-Based drug firm, AstraZeneca has entered into a new field of developing drugs using proteins secreted by the cells called as "Secretome". It has




hera

California-Based Company to Roll Out World's First Stem Cell Therapy On Parkinson's Disease

A California-based company has received approval for trying out the world's first stem therapy on patients affected with mild to severe Parkinson's disease.




hera

Shire Receives Breakthrough Therapy Designation for Rare Diseases Drugs

US Food and Drug Administration has granted breakthrough therapy designation for two experimental drugs for rare diseases conducted by the biotechnology company Shire.




hera

Using Disease-Modifying Therapy for Alzheimer's Disease Treatment

A novel, disease-modifying therapy or treatment for Alzheimer's disease that may involve a whole blood transfusion effectively reduces amyloid plaque




hera

Basudev Behera & Another vs State Of Odisha .... Opp. Party on 11 November, 2024

Heard.

2. At the instance of the petitioner No.2, the F.I.R. in connection with Bari Ramachandrapur P.S. Case No.94 of 2017 corresponding to G.R. Case No.631 of 2017 came to be registered against the petitioner No.1 for the offences punishable under Sections 498(A)/323/325/506/34 of the IPC read with Section 4 of the D.P. Act pending in the Court of learned S.D.J.M., Jajpur.

Page 1 of 4

3. The petitioner No.1 is the husband of the petitioner No.2. Their marriage was solemnized in the year 2016. Few days after their marriage, dissention arose in their family for which the petitioner No.2 lodged the F.I.R. being Bari Ramachandrapur P.S. Case No.94 of 2017 for the above alleged offences.




hera

Wissensspeicher der Frühen Neuzeit : Formen und Funktionen [Electronic book] / herausgegeben von Frank Grunert und Anette Syndikus.

Berlin ; Boston : De Gruyter, [2015]




hera

Lutheran theology : a critical introduction [Electronic book] / Paul R. Hinlicky.

Eugene, Oregon : Cascade Books, [2020]




hera

Humanitarian intervention in the long nineteenth century : Setting the precedent [Electronic book] / Alexis Heraclides, Ada Dialla.

Manchester : Manchester University Press, [2017]




hera

Tuning the phototherapeutic activity of Pt(IV) complexes for bladder cancer via modification of trans N-heterocyclic ligands

Inorg. Chem. Front., 2024, 11,7898-7909
DOI: 10.1039/D4QI01765J, Research Article
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Huayun Shi, Guy J. Clarkson, Peter J. Sadler
The photochemotherapeutic activity of diazido Pt(IV) complexes towards bladder cancer, a common cancer with expensive treatment, has been tuned via modification of trans N-heterocyclic ligands, to give a candidate for preclinical development.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Brachytherapy on-a-chip: a clinically-relevant approach for radiotherapy testing in 3d biology

Lab Chip, 2024, 24,2335-2346
DOI: 10.1039/D4LC00032C, Paper
Rodin Chermat, Elena Refet-Mollof, Yuji Kamio, Jean-François Carrier, Philip Wong, Thomas Gervais
We introduce the first brachytherapy-on-chip device for in vitro testing of brachytherapy on naturally hypoxic tumor spheroids, for translational research and drug development.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Current status of controlled onco-therapies based on metal organic frameworks

RSC Adv., 2024, 14,12817-12828
DOI: 10.1039/D4RA00375F, Review Article
Open Access
Yixuan Yang, Xiaofeng Dai
Most MOFs for controllable cancer treatment act as drug delivery vehicle and/or anti-cancer agent. Molecules with anti-cancer roles such as chemotherapies, gases, peptides or nucleic acids can be loaded into MOFs that decompose in cancer cells or in the TME to release its cargoes.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Construction of glutathione-responsive paclitaxel prodrug nanoparticles for image-guided targeted delivery and breast cancer therapy

RSC Adv., 2024, 14,12796-12806
DOI: 10.1039/D4RA00610K, Paper
Open Access
Weiwei Ma, Qiufeng Zhao, Shilong Zhu, Xinyue Wang, Chuangchuang Zhang, Daming Ma, Na Li, Yanyan Yin
HA-coated redox sensitive visualized nano-prodrug HA/TPE-CS-SS-PTX were exploited in order to highly efficient treatment of cancer and real-time monitoring of drug localization.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Self-supplying Cu2+ and H2O2 synergistically enhancing disulfiram-mediated melanoma chemotherapy

RSC Adv., 2024, 14,13180-13189
DOI: 10.1039/D4RA01075B, Paper
Open Access
Yingqian Gao, Xiaojun Cai, Weijuan Zou, Xiuzhen Tang, Lixian Jiang, Junnian Hao, Yuanyi Zheng, Xinhua Ye, Tao Ying, Ao Li
Disulfiram (DSF) can target and kill cancer cells by disrupting cellular degradation of extruded proteins and has therefore received particular attention for its tumor chemotherapeutic potential.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Decellularization of caprine forestomach rumen tissue modified with silver nanowires as an antibacterial skin substitute scaffold in wound care therapeutics

J. Mater. Chem. B, 2024, Advance Article
DOI: 10.1039/D4TB01560F, Paper
Athmana P. A., Asna Jaleel K. I., Sinduja Malarkodi Elangovan, Riza Paul, Naveen Subbaiyan, Parthiban Shanmugam, Gopal Shankar Krishnakumar
Caprine forestomach native collagen (CFNC) modified with silver nanowires (AgNWs) as a new class of biomimetic xenograft for skin regeneration with strong antimicrobial properties.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Expression of concern: Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer

J. Mater. Chem. B, 2024, Advance Article
DOI: 10.1039/D4TB90175D, Expression of Concern
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Lei Bai, Wenhui Yi, Taiyang Sun, Yilong Tian, Ping Zhang, Jinhai Si, Xun Hou, Jin Hou
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy

J. Mater. Chem. B, 2024, Advance Article
DOI: 10.1039/D4TB01987C, Paper
Wan Huang, Song Zhang, Li Luo, Yalong Pan, Lijun Han, Yao Yu
Novel efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Electronic band structure modulation for sonodynamic therapy

J. Mater. Chem. B, 2024, Accepted Manuscript
DOI: 10.1039/D4TB01679C, Review Article
Yafang Shi, Chengzhilin Li, Linquan Li, Qingbin He, Qingyi Zhu, Ziang Xu, Yanzi Liu, Nianlei Zhang, Meng Zhang, Jianwei Jiao, Runxiao Zheng
Sonodynamic therapy (SDT) is a burgeoning and newfangled therapy modality with great application potential. Sonosensitizers are most essential factors to ensure the effectiveness of SDT. For the past few years,...
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

A dual-functional photosensitizer for mitochondria-targeting photodynamic therapy and synchronous polarity monitoring

J. Mater. Chem. B, 2024, 12,11259-11264
DOI: 10.1039/D4TB01872A, Paper
Liu Yang, Shenglong Gan, Jie Zhang, Yin Jiang, Qingxin Chen, Hongyan Sun
A dual-functional photosensitizer was developed, exhibiting potent phototoxicity and sensitivity to polarity changes.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

J. Mater. Chem. B, 2024, 12,11165-11171
DOI: 10.1039/D4TB01650E, Paper
Fangqing Ge, Yujie Sun, Yu Wang, Dan Yu, Zhijia Wang, Fabiao Yu, Bingran Yu, Hongbing Fu
A H2O2-activatable Bodipy with simultaneous type I and type II photosensitization was designed for tumor imaging and therapy.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Chitosan-functionalized nanobubbles for precision oncology: advances in targeted cancer therapeutics

J. Mater. Chem. B, 2024, 12,11076-11088
DOI: 10.1039/D4TB01930J, Review Article
Vivek Pandey, Tejasvi Pandey
The convergence of nanotechnology and cancer therapeutics has opened new frontiers in the development of advanced drug delivery systems.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

Breakthrough in cancer therapy: lutetium texaphyrin–celecoxib conjugate for immune and photodynamic treatment

J. Mater. Chem. B, 2024, Advance Article
DOI: 10.1039/D4TB02019G, Highlight
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Qihang Ding, Yue Wang, Pengfei Zhang, Ling Mei
Kim et al. present a small-molecule photosensitizer, LuCXB, which combines a COX-2 inhibitor (celecoxib) with a near-infrared lutetium texaphyrin photocatalyst and was loaded CD133-aptamer functionalized exosome for cancer stem cells targeting.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




hera

A guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor for synergistic antibacterial therapy

J. Mater. Chem. B, 2024, 12,11105-11109
DOI: 10.1039/D4TB01840K, Communication
Ruixue Han, Kehan Du, Shengke Li, Minzan Zuo, Ponmani Jeyakkumar, Hao Jiang, Leyong Wang, Xiao-Yu Hu
A guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor has been successfully constructed for synergistic antibacterial therapy.
The content of this RSS Feed (c) The Royal Society of Chemistry